19 June 2013
Keywords: cortex, begins, ph, i/ii, ampalex, pharmaceuticals, collaboration
Article | 24 February 1997
Cortex Pharmaceuticals, in collaboration with the US National Institutesof Health, has begun patient enrollment for a Phase I/IIa trial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 February 1997
© 2013 thepharmaletter.com